A recent FDA webinar for manufacturers of neurological devices that could be cleared for market via the de novo pathway centered on the importance of pre-submission meetings to ensure a smooth regulatory process.
“If you think it's too early to contact us, that is exactly the right time to contact us,” said Carlos...